Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial

被引：0
|
作者：
M. R. McClung
E. M. Lewiecki
M. L. Geller
M. A. Bolognese
M. Peacock
R. L. Weinstein
B. Ding
E. Rockabrand
R. B. Wagman
P. D. Miller
机构：
[1] Oregon Osteoporosis Center,
[2] New Mexico Clinical Research & Osteoporosis Center,undefined
[3] Amgen Inc.,undefined
[4] Bethesda Health Research Center,undefined
[5] Indiana University School of Medicine,undefined
[6] Diablo Clinical Research,undefined
[7] Inc.,undefined
[8] Colorado Center for Bone Research,undefined
来源：
Osteoporosis International | 2013年 / 24卷
关键词：
Bone mineral density; Bone turnover markers; Denosumab; Osteoporosis; RANK ligand;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：227 / 235
页数：8
相关论文
共 50 条
  • [41] Effects of denosumab on bone mineral density and bone turnover in postmenopausal women
    Bone, Henry G.
    Bolognese, Michael A.
    Yuen, Chui Kin
    Kendler, David L.
    Wang, Huei
    Liu, Yu
    Martin, Javier San
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (06): : 2149 - 2157
  • [42] ASSESSMENT OF BONE MINERAL DENSITY AND BONE TURNOVER MARKERS IN POSTMENOPAUSAL WOMEN TRANSITIONED FROM ALENDRONATE TO DENOSUMAB
    Roux, C.
    Brown, J. P.
    Kendler, D. L.
    Lillestol, M.
    Siddhanti, S.
    Man, H. S.
    Martin, J. San
    Bone, H. G.
    Benhamou, C. L.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 10 - 11
  • [43] Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
    Wensel, Terri M.
    Iranikhah, Maryam M.
    Wilborn, Teresa W.
    PHARMACOTHERAPY, 2011, 31 (05): : 510 - 523
  • [44] Effect of exemestane on bone turnover markers and bone mineral density (BMD): 2 year results of the Dutch/Belgian Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial.
    van, Nes J. G. H.
    Papapoulos, S. E.
    Braun, J. J.
    Dirix, L.
    Putter, H.
    Zwaan, R. E.
    Ballieux, B. E. P.
    van Rongen, I
    van de Velde, C. J. H.
    Seynaeve, C.
    Nortier, J. W. R.
    CANCER RESEARCH, 2009, 69 (02) : 152S - 153S
  • [45] Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial
    H. Morii
    Y. Ohashi
    Y. Taketani
    M. Fukunaga
    T. Nakamura
    A. Itabashi
    S. Sarkar
    K. Harper
    Osteoporosis International, 2003, 14 : 793 - 800
  • [46] Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial
    Morii, H
    Ohashi, Y
    Taketani, Y
    Fukunaga, M
    Nakamura, T
    Itabashi, A
    Sarkar, S
    Harper, K
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 (10) : 793 - 800
  • [47] The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosis
    Makras, Polyzois
    Papapoulos, Socrates E.
    Polyzos, Stergios A.
    Appelman-Dijkstra, Natasha M.
    Anastasilakis, Athanasios D.
    BONE, 2020, 138
  • [48] Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
    Bone, Henry G.
    Bolognese, Michael A.
    Yuen, Chui Kin
    Kendler, David L.
    Miller, Paul D.
    Yang, Yu-Ching
    Grazette, Luanda
    San Martin, Javier
    Gallagher, J. Christopher
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04): : 972 - 980
  • [49] Effect of denosumab treatment on bone mineral density and bone turnover markers in osteoporotic patients: real-life experience 2-year follow-up
    Yazan, Ceyda Dincer
    Bugdayci, Onur
    Ilgin, Can
    Yavuz, Dilek Gogas
    ARCHIVES OF OSTEOPOROSIS, 2022, 17 (01)
  • [50] Effect of denosumab treatment on bone mineral density and bone turnover markers in osteoporotic patients: real-life experience 2-year follow-up
    Ceyda Dincer Yazan
    Onur Bugdayci
    Can Ilgin
    Dilek Gogas Yavuz
    Archives of Osteoporosis, 2022, 17
12345